Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

TILADE

NEDOCROMIL SODIUM

Standard Dose
0.5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TILADE is listed in Drugs@FDA under application 020750 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient NEDOCROMIL SODIUM Form and strength SOLUTION;INHALATION - 0.5% Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1997-10-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview TILADE is listed in Drugs@FDA under application 020750 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NEDOCROMIL SODIUM Form and strength SOLUTION;INHALATION - 0.5% Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1997-10-01 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.